These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4316000)

  • 1. The synergistic action of the sulfonamides and the polymyxins against Serratia marcescens.
    Greenfield S; Feingold DS
    J Infect Dis; 1970 May; 121(5):555-8. PubMed ID: 4316000
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro additive effect of polymxin B and rifampin against Serratia marcesen.
    Traub WH; Kleber I
    Antimicrob Agents Chemother; 1975 Jun; 7(6):874-6. PubMed ID: 168807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of the colistin disk test in identification of Serratia marcescens and Serratia liquefaciens.
    von Graevenitz A; Zollinger-Iten J
    Eur J Clin Microbiol; 1987 Feb; 6(1):70-1. PubMed ID: 3032610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between polymyxins, polysorbate and antimetabolites of folic acid synthesis, and a paper disc technique for routine testing for synergism.
    Quesnel LB; Handley PS
    Microbios; 1974 May; 10(40):199-210. PubMed ID: 4369254
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of polymyxin B nonapeptide to augment bactericidal activities of novobiocin, rifampin, and of defibrinated human blood against Serratia marcescens.
    Traub WH; Kohl KH; Spohr M; Bauer D
    Chemotherapy; 1988; 34(3):195-201. PubMed ID: 2843325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro synergistic effects of fisetin and norfloxacin against aquatic isolates of Serratia marcescens.
    Dong J; Ruan J; Xu N; Yang Y; Ai X
    FEMS Microbiol Lett; 2016 Jan; 363(1):fnv220. PubMed ID: 26567906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serratia marcescens: a study of the sensitivity of British isolates to antibacterial agents and their combinations.
    Gray J; McGhie D; Ball AP
    J Antimicrob Chemother; 1978 Nov; 4(6):551-9. PubMed ID: 361679
    [No Abstract]   [Full Text] [Related]  

  • 8. Localization of polysaccharide components in polymyxin B treated cells of Serratia marcescens.
    Weber DA; Nadakavukaren MJ; Tsang JC
    J Antibiot (Tokyo); 1978 Jul; 31(7):732-5. PubMed ID: 211111
    [No Abstract]   [Full Text] [Related]  

  • 9. Ultrastructural changes produced in Proteus vulgaris by a synergistic combination of colistin and sulphadiazine.
    Handley PS; Quesnel LB; Sturgiss MM
    Microbios; 1974 May; 10(40):211-23. PubMed ID: 4369409
    [No Abstract]   [Full Text] [Related]  

  • 10. Polymyxin B-induced cocarde growth phenomenon of Serratia marcescens due to cationic detergent-like activity of polymyxin B.
    Traub WH
    Chemotherapy; 1982; 28(5):363-8. PubMed ID: 6291867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of polymyxin B on outer membrane of Serratia marcescens: activation and dissociation of outer membrane associated alkaline phosphatase.
    Tsang JC; Kranz DM; Brown DA
    J Antibiot (Tokyo); 1977 Mar; 30(3):270-1. PubMed ID: 193812
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of polymyxin B on the synthesis of prodigiosin and its precursors in Serratia marcescens.
    Tsang JC; Feng JS
    J Antibiot (Tokyo); 1983 Nov; 36(11):1564-6. PubMed ID: 6317625
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of polymyxin B on kappa phage adsorption on Serratia marcescens HY.
    Patel KA; Patel IR; Mehta AM; Dave PJ
    Indian J Exp Biol; 1980 Nov; 18(11):1353-4. PubMed ID: 6260637
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement by polymyxin B of proline-induced prodigiosin biosynthesis in non-proliferating cells of Serratia marcescens.
    Lauferska U; Viñas M; Lorén JG; Guinea J
    Microbiologica; 1983 Apr; 6(2):155-62. PubMed ID: 6306401
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergism of aminoglycosides and carbenicillin against resistant strains of Serratia marcescens.
    Lin MY; Tuazon CU; Sheagren JN
    J Antimicrob Chemother; 1979 Jan; 5(1):37-44. PubMed ID: 368005
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the additive effect of polymyxin B and the bactericidal activity of human serum against Serratia marcescens.
    Traub WH; Kleber I
    Chemotherapy; 1975; 21(3-4):189-204. PubMed ID: 169108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural surface alterations of serratia marcescens after exposure to polymyxin B and/or fresh human serum.
    Traub WH; Acker G; Kleber I
    Chemotherapy; 1976; 22(2):104-13. PubMed ID: 176013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The susceptibility of Serratia marcescens to sulfamethoxazole, trimethoprim, and trimethoprim-sulfamethoxazole.
    Adeniyi-Jones C; Neilly S; Roberts RS; Kaufmann NR
    J Infect Dis; 1973 Nov; 128():Suppl:534-42 p. PubMed ID: 4585956
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of a nosocomially significant, multiple drug-resistant strain of Serratia marcescens.
    Traub WH; Kleber I; Pühler A; Burkardt HJ
    Chemotherapy; 1976; 22(5):297-312. PubMed ID: 181215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance and R plasmid in clinical isolates of Serratia marcescens at Shinshu University Hospital.
    Kawakami Y; Okimura Y; Kanai M
    Jpn J Antibiot; 1988 May; 41(5):505-9. PubMed ID: 3063848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.